Residency · New York, NY
Sponsored by Zucker School of Medicine at Hofstra/Northwell
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Rudy Lackner
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,255 citations · Rudy Lackner
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
The New England journal of medicine · 2023 · 739 citations · Gary Deutsch
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 179 citations · Byrne Lee
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 813 citations · Rudy Lackner
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 469 citations · Rudy Lackner
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab.
Cancer discovery · 2021 · 515 citations · Prasad Adusumilli
Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2026 · 36 citations · Rudy Lackner